428 related articles for article (PubMed ID: 25645386)
1. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
[TBL] [Abstract][Full Text] [Related]
2. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
3. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
4. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
5. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
6. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
[TBL] [Abstract][Full Text] [Related]
7. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.
Hughey JR; DiNunzio JC; Bennett RC; Brough C; Miller DA; Ma H; Williams RO; McGinity JW
AAPS PharmSciTech; 2010 Jun; 11(2):760-74. PubMed ID: 20443089
[TBL] [Abstract][Full Text] [Related]
8. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
9. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
10. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
11. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
14. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
15. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
16. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
Zecevic DE; Meier R; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
[TBL] [Abstract][Full Text] [Related]
17. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
18. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
Lang B; Liu S; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
[TBL] [Abstract][Full Text] [Related]
20. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
